These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37580537)

  • 1. Common treatment strategies for calcium hydroxyapatite deposition disease: a cost-effectiveness analysis.
    Alaia EF; Subhas N; Da Silva Cardoso M; Li ZI; Shah MR; Alaia MJ; Gyftopoulos S
    Skeletal Radiol; 2024 Mar; 53(3):437-444. PubMed ID: 37580537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-rich plasma vs. corticosteroid injections for the treatment of recalcitrant lateral epicondylitis: a cost-effectiveness Markov decision analysis.
    Klifto KM; Colbert SH; Richard MJ; Anakwenze OA; Ruch DS; Klifto CS
    J Shoulder Elbow Surg; 2022 May; 31(5):991-1004. PubMed ID: 35031496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyzing cost-effectiveness of ulnar and median nerve transfers to regain forearm flexion.
    Wali AR; Park CC; Brown JM; Mandeville R
    Neurosurg Focus; 2017 Mar; 42(3):E11. PubMed ID: 28245686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland.
    Soini E; Virtanen O; Väätäinen S; Briere JB; Bowrin K; Millier A
    Adv Ther; 2020 Jul; 37(7):3348-3369. PubMed ID: 32519113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Advanced Imaging to Assess Rotator Cuff Integrity Before Shoulder Arthroplasty Cost-effective? A Decision Modeling Study.
    Levin JM; Wickman J; Lazarides AL; Cunningham DJ; Goltz DE; Mather RC; Anakwenze O; Lassiter TE; Klifto CS
    Clin Orthop Relat Res; 2022 Jun; 480(6):1129-1139. PubMed ID: 35014977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-Rich Plasma Versus Corticosteroid Injections for the Treatment of Mild-to-Moderate Carpal Tunnel Syndrome: A Markov Cost-Effectiveness Decision Analysis.
    Klifto KM; Klifto CS; Pidgeon TS; Richard MJ; Ruch DS; Colbert SH
    Hand (N Y); 2024 Jan; 19(1):113-127. PubMed ID: 35603672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service.
    Armeni P; Borsoi L; Fornaro G; Jommi C; Colombo N; Costa F
    Clin Ther; 2020 Jul; 42(7):1192-1209.e12. PubMed ID: 32591103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of vibegron for the treatment of overactive bladder in the United States.
    Chen JV; Klein TM; Nesheim J; Mudd PN
    J Med Econ; 2022; 25(1):1092-1100. PubMed ID: 35993729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of nonoperative management versus open and laparoscopic surgery for uncomplicated acute appendicitis in Colombia.
    Guevara-Cuellar CA; Rengifo-Mosquera MP; Parody-Rúa E
    Cost Eff Resour Alloc; 2021 Jun; 19(1):34. PubMed ID: 34112179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seven-year cost-effectiveness of ProDisc-C total disc replacement: results from investigational device exemption and post-approval studies.
    Radcliff K; Lerner J; Yang C; Bernard T; Zigler JE
    J Neurosurg Spine; 2016 May; 24(5):760-8. PubMed ID: 26824587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplemental Optoacoustic Imaging of Breast Masses: A Cost-Effectiveness Analysis.
    Ozcan BB; Xi Y; Dogan BE
    Acad Radiol; 2024 Jan; 31(1):121-130. PubMed ID: 37748954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of magnetic resonance imaging versus ultrasound for the detection of symptomatic full-thickness supraspinatus tendon tears.
    Gyftopoulos S; Guja KE; Subhas N; Virk MS; Gold HT
    J Shoulder Elbow Surg; 2017 Dec; 26(12):2067-2077. PubMed ID: 28893546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness Analysis of Combined Dual Motor Nerve Transfers versus Alternative Surgical and Nonsurgical Management Strategies to Restore Shoulder Function Following Upper Brachial Plexus Injury.
    Khalifeh JM; Dibble CF; Dy CJ; Ray WZ
    Neurosurgery; 2019 Feb; 84(2):362-377. PubMed ID: 30371909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan.
    Kobayashi T; Hoshi M; Yuasa A; Arai S; Ikeda M; Matsuda H; Kim SW; Hibi T
    Pharmacoeconomics; 2023 May; 41(5):589-604. PubMed ID: 36884164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of Recurrent Dupuytren Contracture Treatment.
    Yoon AP; Kane RL; Hutton DW; Chung KC
    JAMA Netw Open; 2020 Oct; 3(10):e2019861. PubMed ID: 33030553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fexapotide triflutate vs oral pharmacotherapy as initial therapy for moderate-to-severe benign prostate hyperplasia patients: a cost-effectiveness analysis.
    Wei Y; Hay JW; Hay AR; Suen SC
    BMC Urol; 2022 May; 22(1):76. PubMed ID: 35550071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of fingolimod, teriflunomide, dimethyl fumarate and intramuscular interferon-β1a in relapsing-remitting multiple sclerosis.
    Zhang X; Hay JW; Niu X
    CNS Drugs; 2015 Jan; 29(1):71-81. PubMed ID: 25326785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.